GlobalData on MSN9h
Galderma enters fierce European atopic dermatitis market with Nemluvio approval
Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...
Agence France-Presse16h
Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...
Galderma's Nemluvio® (Nemolizumab) Approved In The European Union For Moderate-To-Severe Atopic Dermatitis And Prurigo N...
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...
Medindia5d
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis
Silverberg, J.I., Rosmarin, D., Chovatiya, R.  et al.  The regulatory T cell-selective interleukin-2 receptoragonist rezpegaldesleukin in the treatment of inflammatory ...
Managed Healthcare Executive10d
Tapinarof Cream Improves Symptoms and Quality of Life in Children with Severe Atopic Dermatitis
Tapinarof, however, offers a potential solution by improving the skin barrier, reducing inflammation and relieving itch ...
The American Journal of Managed Care3d
AI-Enabled Wearable Sensor Reduces Scratching in Atopic Dermatitis
Patients with mild atopic dermatitis who reported nighttime scratching experienced relief when they used an artificial intelligence (AI)-powered wearable sensor that delivered haptic feedback on sleep ...
Atopic Dermatitis Affects Millions, And Johnson & Johnson Is Committed To Addressing The Unmet Needs Of Patients
AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do not address the multiple inflammatory pathways that cause its specific ...
Mirage News16h
EU Greenlights Galderma's Nemluvio for Skin Conditions
Ad hoc announcement pursuant to Art. 53 LR This approval from the European Commission is based on robust results from the phase III OLYMPIA and ...
MedPage Today4d
Roflumilast Cream 0.15% May Be Powerful New Tool Against Atopic Dermatitis
Opens in a new tab or window Once-daily roflumilast cream at 0.15% improved symptoms of atopic ... a range of treatments, unmet needs persist. First, crisaborole and the topical calcineurin ...
Pharmabiz3d
US FDA grants fast track designation to Nektar Therapeutics’ rezpegaldesleukin to treat moderate-to-severe atopic dermatitis
US FDA grants fast track designation to Nektar Therapeutics’ rezpegaldesleukin to treat moderate-to-severe atopic dermatitis: San Francisco Tuesday, February 11, 2025, 16:00 Hrs ...
Medscape3d
Efficacy and Safety Considerations in Topical Treatments for Atopic Dermatitis
Atopic dermatitis skin is deficient in antimicrobial ... the induction of corticosteroid insensitivity, which complicates treatment response to corticosteroid therapy in patients with AD (Hauk ...
Medindia27d
Dupilumab for Atopic Dermatitis a Marketing Success
Dupilumab is prescribed for treating moderate-to-severe atopic dermatitis in adult patients who do not respond to topical treatments or cannot tolerate standard therapies. It acts as an ...